Published in
Esmo Open, Esmo Open, 4(8), p. 101589, 2023
DOI: 10.1016/j.esmoop.2023.101589
Links
Tools
A phase Ib/II dose expansion study of subcutaneous sasanlimab in patients with locally advanced or metastatic non-small-cell lung cancer and urothelial carcinoma
Journal article published in 2023 by
B. C. Cho 
,
K. Penkov,
I. Bondarenko,
A. Kurochkin,
J. Pikiel,
H. K. Ahn,
M. E. Korożan,
M. Osipov,
S. Odintsova,
F. Braiteh,
A. Ribas,
J. E. Grilley-Olson,
I. Lugowska,
V. Bonato,
M. A. Damore
and other authors.
,
K. Penkov,
I. Bondarenko,
A. Kurochkin,
J. Pikiel,
H. K. Ahn,
M. E. Korożan,
M. Osipov,
S. Odintsova,
F. Braiteh,
A. Ribas,
J. E. Grilley-Olson,
I. Lugowska,
V. Bonato,
M. A. Damore
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 